Home » Topics » Regulatory

Regulatory
RSS

Lamictal approved for adjunctive use in pediatric partial seizures

Jan. 23, 2003

Asmanex Twisthaler launched in U.K.

Jan. 23, 2003

E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment

Jan. 22, 2003

Chiesi's budesonide Modulite pMDI approved in Germany

Jan. 21, 2003

Novartis seeks approval for lower dose of Estalis in Sweden

Jan. 21, 2003

Caelyx approved in E.U. for metastatic breast cancer

Jan. 16, 2003

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

Approval of Coreg recommended for heart attack patients with impaired cardiac function

Jan. 15, 2003

Infliximab granted priority review by the FDA for fistulizing CD

Jan. 13, 2003

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

Jan. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...